Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

PCOS kidney link explored in new study

NCT ID NCT07441811

Knowledge-focused Sponsor: Uşak University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 300 women with different types of PCOS and healthy women to see if kidney function and urine protein levels differ. Researchers measured urine albumin-to-creatinine ratio and estimated glomerular filtration rate. The goal was to understand if certain PCOS types have higher risk for kidney issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

300 people

The number who actually took part.

Started

Apr 2022

Finished

Jul 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Woman aged between 18 and 35 years, age-matched between groups, diagnosed with PCOS and without cancer diagnosis, liver and kidney failure, not taking medications like ACEI and ARB\'s, and without active infection. \-

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients who applied for reasons such as hair growth, acne, menstrual irregularity or infertility and were diagnosed with PCOS after examination, biochemical, hormonal and sonographic tests, 2. Female patients between the ages of 18-35, 3. Patients without known cancer, liver or kidney failure, 4. Patients who do not take drugs, ACEIs and ARBs. 5. Female patients without active infection will be included. - Exclusion Criteria: 1. Female patients \<18 years of age and \>35 years of age, 2. Patients with known cancer, liver and kidney failure, 3. Patients taking drugs, ACEIs and ARBs, 4. Patients with active infection will not be included in the study. -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Glomerular filtration rate are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Glomerular filtration rate Polycystic ovary syndrome Urine albumin \(ualb\) Urine creatinine \(ucr\)

Contacts and locations

Locations

  • Usak Egitim Ve Araştırma Hastanesi

    Uşak, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.